Refractory, locally advanced Basal cell carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB09143 | Sonidegib | An antineoplastic agent used for the treatment of locally advanced recurrent basal cell carcinoma (BCC) following surgery and radiation therapy, or in cases where surgery or radiation therapy are not appropriate. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09143 | Sonidegib | Smoothened homolog | target |
DB09143 | Sonidegib | Cytochrome P450 3A4 | enzyme |
Drug | Drug Name | Phase | Status | Count |
---|